Related Experiment Video

Updated: Aug 8, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

PI 3-kinases: hidden potentials revealed

Peter K Vogt1, Andreas G Bader, Sohye Kang

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA. pkvogt@scripps.edu

Cell Cycle (Georgetown, Tex.)
|May 12, 2006
PubMed

Insights

Phosphoinositide 3-kinases (PI 3-kinases) drive cancer through mutations or overexpression. PIK3CA mutations are oncogenic and targeted by inhibitors, while other PI 3-kinase isoforms warrant further investigation for their role in cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Phosphoinositide 3-kinases (PI 3-kinases) are crucial signaling enzymes implicated in cell growth, proliferation, and survival.
  • Aberrant PI 3-kinase signaling is a hallmark of many human cancers, contributing to tumorigenesis and progression.

Purpose of the Study:

  • To elucidate the mechanisms by which PI 3-kinases contribute to oncogenesis.
  • To identify PI 3-kinase isoforms and their specific alterations as potential therapeutic targets in cancer treatment.

Main Methods:

  • Analysis of cancer-specific mutations in PIK3CA, the gene encoding the p110alpha catalytic subunit of PI 3-kinase.
  • Investigating the oncogenic transformation induced by overexpression of wild-type PI 3-kinase non-alpha isoforms (p110beta, gamma, and delta) in cell culture models.

Main Results:

  • Cancer-associated mutations in PIK3CA confer oncogenic activity in preclinical models.
  • These PIK3CA mutations are key drivers of the oncogenic cellular phenotype in human tumors.
  • Overexpression of wild-type p110beta, p110gamma, and p110delta isoforms induces oncogenic transformation in cell culture, suggesting a role beyond mutations.

Conclusions:

  • Mutations in PIK3CA are significant oncogenic drivers and promising targets for small molecule inhibitors.
  • While not found mutated in human cancer, deregulated expression of non-alpha PI 3-kinase isoforms may contribute to oncogenic properties and requires further research.

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...